MM+M’s Stephen Madden sits down with Janis Cohen and Dan Weber of Havas Health & You to discuss their pro-bono work seeking to destigmatize mental illness and more.
Running (and caring) on fumes: Nurses remain under siege
MM+M’s Stephen Madden sits down with Dr. Maria Rivas, chief medical officer and SVP global patient safety/medical affairs & evidence & value development at EMD Serono, to talk about the drugmaker’s “patient-directed” approach to drug development and more.
Live at Pharma USA: GSK’s Michael Petroutsas and ViiV’s Frank Spinelli on building trust with patients
MM+M’s Stephen Madden sits down with Michael Petroutsas, SVP, US oncology business unit at GSK, and Frank Spinelli, medical director, patient affairs U.S. at ViiV Healthcare.
Live at Pharma USA: Organon CCO Wendy Lund on going exactly where ‘she’ is
MM+M’s Stephen Madden sits down with Wendy Lund, chief communications officer for Organon, to talk about how she elevated the focus of women and health to a business imperative and more.
Live at Pharma USA: Kite CEO Christi Shaw on why cell therapy is a team sport
MM+M’s Stephen Madden sits down with Christi Shaw, CEO of Kite, a Gilead Company, on the floor of the Pharma USA conference to talk about how the biotech company utilized teamwork to navigate supply and more.
Mapping the identity experience in digital health communications, a podcast presented by GCI Health
Subin Baral, global life sciences deals leader at EY, shares his research-based predictions for where biopharma dealmaking could be headed in the second half.